ClinicalTrials.Veeva

Menu

Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study (TNT-HIV)

T

Thai Red Cross AIDS Research Centre

Status

Completed

Conditions

Healthy
HIV Infection

Study type

Observational

Funder types

Other
NETWORK

Identifiers

NCT01634477
TNT-HIV 003

Details and patient eligibility

About

  1. To describe the morbidity and clinical characteristics among HIV-infected patients and HIV-uninfected patients.
  2. To identify the risk factors for the complication or morbidity among HIV-infected patients and HIV-uninfected patients.
  3. To describe the mortality among HIV-infected patients and HIV-uninfected patients.
  4. To identify the risk factors for the cause of death among HIV-infected and HIV-uninfected patients.

Full description

The information obtained from this study would be very important in planning future holistic care of HIV-infected patients in our institutes as well as in national policy. Results from the study could be used to develop proper long-term management guidelines for people living with HIV (PLHIV) in Thailand targeted at preventable conditions such as metabolic diseases and certain cancers.

Enrollment

816 patients

Sex

All

Ages

30+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

HIV-infected patients group

  • HIV positive
  • 30 years of age or older, both male and female
  • Thai nationality
  • Written research informed consent

HIV-uninfected patients group

  • HIV un-infected
  • 30 years of age or older, both male and female
  • Thai nationality
  • Written research informed consent

Exclusion criteria

HIV-infected patients group

  • Systolic BP ≥ 130 or Diastolic BP ≥ 85mm Hg or on the treatment
  • Fasting blood sugar > 126 mg/dl or on the treatment
  • Proteinuria
  • Creatinine > 1.5 mg/dl
  • Recent hospitalization
  • Patient who are having mental disease HIV-uninfected patients group
  • Systolic BP ≥ 130 or Diastolic BP ≥ 85mm Hg or on the treatment
  • Fasting blood sugar > 126 mg/dl or on the treatment
  • Proteinuria
  • Creatinine > 1.5 mg/dl
  • Recent hospitalization
  • Patient who are having mental disease

Trial design

816 participants in 2 patient groups

HIV-infected patients group
Description:
HIV positive
HIV-uninfected patients group
Description:
HIV negative

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems